|
HOMER1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.78860284758298E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01399999508089E-11 |
| Normal-vs-Stage2 |
2.297700E-03 |
| Normal-vs-Stage3 |
1.07340003552281E-09 |
| Normal-vs-Stage4 |
7.83080045252404E-10 |
| Stage1-vs-Stage2 |
2.430300E-02 |
| Stage1-vs-Stage3 |
4.039000E-01 |
| Stage1-vs-Stage4 |
8.552200E-02 |
| Stage2-vs-Stage3 |
1.497730E-02 |
| Stage2-vs-Stage4 |
2.395500E-03 |
| Stage3-vs-Stage4 |
3.476600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.96285218581716E-12 |
| Normal-vs-AfricanAmerican |
2.539400E-01 |
| Normal-vs-Asian |
3.51789997132812E-09 |
| Caucasian-vs-AfricanAmerican |
2.218600E-01 |
| Caucasian-vs-Asian |
2.393000E-01 |
| AfricanAmerican-vs-Asian |
1.315590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1450996534611E-10 |
| Normal-vs-Female |
1.02980002303354E-09 |
| Male-vs-Female |
2.939000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72120000474507E-08 |
| Normal-vs-Age(41-60Yrs) |
3.19580029106703E-10 |
| Normal-vs-Age(61-80Yrs) |
3.59610000000288E-05 |
| Normal-vs-Age(81-100Yrs) |
1.874050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.982400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.590000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.754600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.150800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.592800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.868000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.633710E-04 |
| Classical-VS-Follicular |
2.008400E-01 |
| Classical-VS-Other |
1.738190E-01 |
| Classical-VS-Normal |
3.10399994596366E-09 |
| Tall-VS-Follicular |
3.82399999999672E-05 |
| Tall-VS-Other |
6.973400E-01 |
| Tall-VS-Normal |
1.37699851521234E-11 |
| Follicular-VS-Other |
6.142500E-02 |
| Follicular-VS-Normal |
2.11270000000097E-05 |
| Other-VS-Normal |
7.038700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.26540000489462E-08 |
| Normal-vs-N1 |
2.01400000010565E-08 |
| N0-vs-N1 |
2.080200E-01 |
|
|
